Dynavax Technologies (LTS:0IDA) Days Sales Outstanding : 76.15 (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Dynavax Technologies Days Sales Outstanding?

Dynavax Technologies's average Accounts Receivable for the three months ended in Mar. 2024 was $42.4 Mil. Dynavax Technologies's Revenue for the three months ended in Mar. 2024 was $50.8 Mil. Hence, Dynavax Technologies's Days Sales Outstanding for the three months ended in Mar. 2024 was 76.15.

The historical rank and industry rank for Dynavax Technologies's Days Sales Outstanding or its related term are showing as below:

LTS:0IDA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.94 Med: 80.79 Max: 1225.6
Current: 85.35

During the past 13 years, Dynavax Technologies's highest Days Sales Outstanding was 1225.60. The lowest was 38.94. And the median was 80.79.

LTS:0IDA's Days Sales Outstanding is ranked worse than
64.53% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.845 vs LTS:0IDA: 85.35

Dynavax Technologies's Days Sales Outstanding declined from Mar. 2023 (240.03) to Mar. 2024 (76.15).

Dynavax Technologies Days Sales Outstanding Historical Data

The historical data trend for Dynavax Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dynavax Technologies Days Sales Outstanding Chart

Dynavax Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

65.24

122.28

57.53

66.00

145.93

Dynavax Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															240.03	109.79	58.80	71.36	76.15

Competitive Comparison of Dynavax Technologies's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Dynavax Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dynavax Technologies's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dynavax Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Dynavax Technologies's Days Sales Outstanding falls into.

Dynavax Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Dynavax Technologies's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (145.13	+	40.607)	/	2 )	/	232.284	*	365
=	92.8685					/	232.284	*	365
=	145.93

Dynavax Technologies's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (40.607	+	44.161)	/	2 )	/	50.79	*	365 / 4
=	42.384					/	50.79	*	365 / 4
=	76.15

Dynavax Technologies (LTS:0IDA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Dynavax Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Dynavax Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Dynavax Technologies (LTS:0IDA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dynavax Technologies Corp (LTS:0IDA) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

DVAX:USA DYF1:Germany

Address

2100 Powell Street, Suite 900, Emeryville, CA, USA, 94608

Website

https://www.dynavax.com

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Dynavax Technologies (LTS:0IDA) Headlines

No Headlines